Market experts have identified specific opportunities for investors looking to enter the equity market on Tuesday, December 23, 2025. Somil Mehta, who heads Alternate Research and Capital Market Strategy at Mirae Asset Sharekhan, has recommended three stocks that show promising technical setups for potential gains.
Detailed Technical Analysis and Trading Strategy
According to Mehta's research, the selected stocks are exhibiting classic breakout patterns and momentum shifts, providing a favourable risk-reward scenario for traders and investors. The recommendations come with precise entry points, stop-loss levels, and price targets.
NMDC: Poised for an Uptrend Resumption
NMDC is advised as a 'Buy' in the price band of Rs 78 to Rs 79. Investors should place a stop-loss order at Rs 75 to manage downside risk. The identified target price for this trade is Rs 86.
The analysis indicates that NMDC has been consolidating within a range for approximately fifteen weeks, consistently trading above its 20-day and 40-day daily moving averages. The stock is now showing a breakout from this range, finding reliable support at the 10-day moving average, which is positioned near Rs 76.20. This pattern suggests the stock is ready to resume its prior upward trajectory.
Supporting this bullish view, key momentum indicators have completed a positive crossover above the zero line. For traders monitoring key levels, immediate resistance is seen at Rs 83, while strong support lies at Rs 77.
Glenmark Pharmaceuticals: Breaking the Falling Trendline
For Glenmark Pharmaceuticals, the 'Buy' range is between Rs 2036 and Rs 2037. A strict stop-loss is recommended at Rs 1890, with a profit-taking target set at Rs 2200.
The stock's chart reveals a significant technical development: it has broken out above a falling trendline while also staying above its 20-day and 40-day moving averages. This breakout is a strong signal that the prevailing downtrend may be reversing.
Furthermore, Glenmark had been trading in a broad range over the past two weeks and has now decisively broken above this range, surpassing the 20-day moving average at Rs 1954. The momentum indicators align with the price action, showing a positive crossover. Key levels to watch include resistance at Rs 2100 and support at Rs 1960.
BHEL: Consolidation Nearing a Breakout
The third recommendation is BHEL, with a suggested 'Buy' range of Rs 281 to Rs 282. To protect capital, a stop-loss should be set at Rs 266. The expected target for this setup is Rs 310.
BHEL's price action shows it has been consolidating within a broad range for the past month. Importantly, it has maintained its position above the short-to-medium-term 20-day and 40-day moving averages throughout this phase. Technical analysis suggests the stock is on the verge of a breakout above this consolidation zone.
The momentum indicators are displaying strength, having recently generated a positive crossover signal. Adding to the bullish evidence, the stock price has already crossed above its 20-day moving average, which is at Rs 278.40. The immediate resistance for BHEL is at Rs 293, with support established at Rs 272.
Important Disclaimer for Investors
It is crucial for investors to note that these recommendations and market views are the independent analysis of the expert, Somil Mehta of Mirae Asset Sharekhan. They do not represent the official stance of The Times of India. All investment and trading decisions in the stock market or other asset classes carry inherent risk. Investors are advised to consider their own financial situation, risk appetite, and consult with certified financial advisors before acting on any market recommendations.